Major trial tests new pill to slow Alzheimer's decline
Disease control
Completed
This study tested whether a daily pill called TRx0237 could safely slow the progression of Alzheimer's disease. It involved 598 people with mild to moderate Alzheimer's who took either the drug or a placebo for one year. The main goals were to see if the drug could help people ma…
Phase: PHASE3 • Sponsor: TauRx Therapeutics Ltd • Aim: Disease control
Last updated Apr 02, 2026 02:11 UTC